Skip to main content
. 2020 Oct 11;26:e928054-1–e928054-13. doi: 10.12659/MSM.928054

Table 1.

Clinicopathological characteristics of patients.

Variables SSI(−) (N=261)
n (%)/mean±sd
SSI(+) (N=65)
n (%)/mean±sd
Statistic P
Sex 0.144* 0.704
 Male 162 (62.1) 42 (64.6)
 Female 99 (37.9) 23 (35.4)
Age (y) 57.85±11.749 61.06±11.511 1.920** 0.056
BMI ≥25 kg/m2 0.104* 0.747
 Yes 57 (21.8) 52 (80.0)
 No 204 (78.2) 13 (20.0)
Preoperative CEA (ng/ml) 7.86±17.156 9.715±14.53 0.800** 0.424
Preoperative CA125 (ng/ml) 16.00±18.959 21.758±29.248 1.509** 0.135
Preoperative CA199 (ng/ml) 33.57±122.680 63.92±176.309 1.311** 0.194
Preoperative Serum albumin (g/L) 40.08±4.576 40.07±4.564 0.007** 0.995
Preoperative hemoglobin (g/L) 118.28±22.021 120.23±22.632 0.637** 0.525
Tumor size (cm) 4.43±2.026 4.44±1.704 0.057** 0.955
Adjuvant chemotherapy 3.239* 0.072
 Yes 20 (7.7) 1 (1.5)
 No 241 (92.3) 64 (98.5)
Operation time (hour) 3.57±1.112 3.72±1.045 0.998** 0.319
Postoperative hospitalization dates 12.53±3.636 25.35±17.044 6.031** <0.001
Blood transfusion 0.650* 0.420
 Yes 75 (28.7) 22 (33.8)
 No 186 (71.3) 43 (66.2)
Anastomotic leakage 135.364* <0.001
 Yes 3 (1.1) 34 (52.3)
 No 258 (98.9) 31 (47.7)
Preoperative obstruction 0.011* 0.916
Yes 74 (28.4) 18 (27.7)
No 187 (71.6) 47 (72.3)
Lymph node involvement 0.568* 0.451
 Yes 122 (46.7) 27 (41.5)
 No 139 (53.3) 38 (58.5)
ASA score 0.537* 0.911
 I 7 (2.7) 2 (3.1)
 II 171 (65.5) 41 (63.1)
 III 62 (23.8) 15 (23.1)
 IV 21 (8.0) 7 (10.8)
Tumor location 0.659* 0.417
 Colon 142 (54.4) 39 (60.0)
 Rectum 119 (45.6) 26 (40.0)
Operative approach 3.048* 0.081
 Open 90 (34.5) 30 (46.2)
 Laparoscopic 171 (65.5) 35 (53.8)
Differentiation 2.506* 0.113
 Well 235 (90.0) 54 (83.1)
 Poor 26 (10.0) 11 (16.9)
T stage 4.481* 0.214
 I 16 (6.1) 3 (4.6)
 II 28 (10.7) 13 (20.0)
 III 193 (73.9) 45 (69.2)
 IV 24 (9.2) 4 (6.2)

ASA score – American Society of Anesthesiologists score; sd – standaed deviation. SSI – surgical site infection; BMI – body mass index.

*

Chi-square test;

**

t-test.